Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
Avenue Therapeutics, Inc. (ATXI)
Today's Latest Price: $6.26 USD
Updated Jan 27 4:00pm
Add ATXI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ATXI Stock Price Chart Interactive Chart >
ATXI Price/Volume Stats
| Current price | $6.26 | 52-week high | $12.34 |
| Prev. close | $6.42 | 52-week low | $2.85 |
| Day low | $6.03 | Volume | 115,718 |
| Day high | $6.54 | Avg. volume | 141,724 |
| 50-day MA | $4.94 | Dividend yield | N/A |
| 200-day MA | $8.30 | Market Cap | 104.84M |
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
Loading social stream, please wait...